Eastern Europe-focused private equity firm Mid Europa Partners is reportedly nearing the half-way mark for its €1bn-targeting fourth fundraise.
Dow Jones reported the news, pointing out the firm was trumping a difficult fundraising environment for the region’s buyout market.
A report from PEI in July suggested Mid Europa was eyeing a first close within months for Fund IV, which has a €1.25bn hard cap.
AltAssets revealed last September that the firm had hired Credit Suisse to place Fund IV, although at that stage it had not decided on a target.
At the time MEP highlighted a string of exits it planned to make to help fire up the fundraise, including Polish healthcare company Lux Med.
Last month Mid Europa made its second bolt-on deal in the Central European laboratory space in the space of a week with Diagnostyka’s acquisition of Polish pathology company Olympus Consilio.
This transaction marked a further step in Mid Europa’s strategy to consolidate the market, it said.
Earlier the firm had announced the acquisition of Euromedic Labs in the Czech Republic.
Copyright © 2013 AltAssets